rs78338172
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000352.6(ABCC8):c.4545+13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000382 in 1,613,384 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000352.6 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00197 AC: 300AN: 152196Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000534 AC: 134AN: 250784Hom.: 0 AF XY: 0.000383 AC XY: 52AN XY: 135784
GnomAD4 exome AF: 0.000217 AC: 317AN: 1461070Hom.: 1 Cov.: 32 AF XY: 0.000209 AC XY: 152AN XY: 726804
GnomAD4 genome AF: 0.00197 AC: 300AN: 152314Hom.: 1 Cov.: 33 AF XY: 0.00208 AC XY: 155AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:2
Variant summary: ABCC8 c.4545+13C>T alters a conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00053 in 250784 control chromosomes, predominantly at a frequency of 0.007 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 2-fold of the estimated maximal expected allele frequency for a pathogenic variant in ABCC8 causing Congenital Hyperinsulinism phenotype (0.0034), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.4545+13C>T has been reported in the literature as a benign change in individuals affected with Congenital Hyperinsulinism (example, Snider_2013). These report(s) do not provide unequivocal conclusions about association of the variant with Congenital Hyperinsulinism. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 23275527). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
not provided Benign:2
- -
- -
Maturity onset diabetes mellitus in young Uncertain:1
Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs78338172) in MODY yet. -
Transitory neonatal diabetes mellitus Uncertain:1
Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs78338172 ) in neonatal diabetes yet. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at